France· FR:67971107
MAGNESIUM ARROW CONSEIL 150 mg, comprimé effervescent
A medicinal product containing oxyde de magnésium léger, registered in France by ARROW GENERIQUES.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OXYDE DE MAGNÉSIUM LÉGER
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip133400933413514plaquette(s) papier aluminium P-A-M-éthylène (SURLYN) de 20 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Oxyde de magnésium léger in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBestmade Natural Products Mag CarbBestmade Natural Products
- United Kingdom100 M-Trate capsulesTriOn Pharma Ltd
- SwitzerlandAndreamag
- BelgiumCarbobel SimplexMedgenix Benelux
- Japanクエン酸マグネシウム堀井薬品工業
- NorwayEmgesanMeda AS
- GermanyBiolectra ForteHermes Arzneimittel Gmbh
- CzechiaMAGNESII LACTICI 0,5 TBL. MEDICAMENTAGlenmark Pharmaceuticals s.r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Biolectra, Dr. Böhm Direkt
- Belgium · Magmedi, Magneclo
- Bulgaria · Диаспорал Директ, Магнезиев Диаспорал
- Cyprus · Magnesia San Pellegrino
- Czechia · Magnesii Lactici Medicamenta, Magnesium Lactate Biomedica
- Germany · Biolectra Forte, Biolectra Forte Orangengeschmack
- Denmark · Diasporal, Magnesia
- Estonia · Magnesium Diasporal Protina Pharmazeutische Gesellschaft Mbh, Magnesium Diasporal Protina Pharmazeutische Gmbh
- Spain · Magnesia Cinfa, Magnesia Lainco
- Finland · Emgesan, Magnesiamaito
- United Kingdom (Northern Ireland) · Magnaspartate, Magnesium Hydroxide Mixture Brown & Burk Uk
- Greece · Chymexan, Davimag
- Hungary · Antagel M, Magnesii Citrici Naturland
- Ireland · Magmedi, Magnence
- Iceland · Magnesia Dak
- Italy · Citrato Espresso Gabbiani, Magnesia
- Lithuania · Diasporal, Diasporal Direct
- Luxembourg · Emge, Mag 2
- Latvia · Diasporal, Magnesium Diasporal Direct Protina Pharmazeutische
- Malta · Magnesia
- Netherlands · Magmedi, Magnence
- Norway · Nycoplus
- Poland · Magnezin, Slow-Mag
- Portugal · Leite De Magnésia Phillips, Magnoral
- Sweden · Magnesium Eql Pharma, Magnesium Evolan
- Slovenia · Magnesium Protina, Magnesol
- Slovakia · Magnesii Lactas Galvex, Magnesii Lactas Vulm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/30fc9e01-34a3-4edd-8887-9986a681c966 GET /v1/drugs/30fc9e01-34a3-4edd-8887-9986a681c966?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "67971107",
"date_amm": "1991-08-13",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "OXYDE DE MAGNÉSIUM LÉGER",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé effervescent(e)",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about oxyde de magnésium léger.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.